Thanks Anne. Good points worth noting. Best regards, Jeffrey J Neuman (202) 549-5079 Jeff.Neuman@comlaude.com ________________________________ From: Aikman-Scalese, Anne <AAikman@lrrc.com> Sent: Thursday, September 26, 2019 7:42:44 PM To: Jeff Neuman <jeff.neuman@comlaude.com>; Rubens Kuhl <rubensk@nic.br>; gnso-newgtld-wg@icann.org <gnso-newgtld-wg@icann.org> Subject: RE: Name Collision Topic [New Subject Line] Thanks Jeff. This looks accurate to me. In terms of public comment received, I note that the Board advised us there was an opportunity to collaborate with NCAP so I think the WG should also note that you have become a member of the NCAP Discusssion Group for that purpose. I also note that I believe Rubens, Justine, and I are also members of the NCAP Discussion Group. Not sure who else in Sub Pro may have joined and not sure how many are planning to attend the NCAP meeting November 1 in Montreal. I do think it’s important for the WG to note our cooperation with NCAP. This should include trying to work out timing issues as we move forward. Anne From: Gnso-newgtld-wg <gnso-newgtld-wg-bounces@icann.org> On Behalf Of Jeff Neuman Sent: Wednesday, September 25, 2019 1:56 AM To: Rubens Kuhl <rubensk@nic.br>; gnso-newgtld-wg@icann.org Subject: [Gnso-newgtld-wg] Name Collision Topic [New Subject Line] [EXTERNAL] ________________________________ Thanks Anne and Rubens for this discussion. I think in moving forward, we may have to tackle the name collision issue with the following in mind: 1. We will need to reflect the work we have done in Work Track 4 as well as the comments we received and the discussions/materials we have received to date. This includes the JAS Final report. 2. We should note the Board Resolution which resulted ultimately in the approval of the work described in Phase 1 of the NCAP Study as reported in the Scope of Work published by the NCAP: * Scope: (https://community.icann.org/display/NCAP/NCAP+Working+Documents?preview=/794...) * Board Resolution: https://features.icann.org/name-collision-analysis-project-%E2%80%93-first-s... 3. We should note that there MAY be other phases of the NCAP study and describe those phases. See https://community.icann.org/download/attachments/79437474/NCAP%20Proposal%20.... But we also have to recognize that that is not a given. There may or may not ever be a Phase 2 or 3 study. 4. In the event that there are other studies, there are recommendations that this Working Group has with respect to things we would like to see studied (eg., a do not apply list, an evaluation testing procedure, etc.). 5. In the event that there are no future studies, we will need to see what our group has consensus on (if anything). 6. If there is no consensus on anything, then we will need to report on that and ultimately what happened in the last round would be recommended. Note: We will also need to see if anything comes from the letter sent from the GNSO Council to the ICANN Board on the dependencies for the next round and if that does have an impact on our recommendations. Please let me know if you have any issues with my summary. Best regards, Jeff Neuman Senior Vice President Com Laude | Valideus D: +1.703.635.7514 E: jeff.neuman@comlaude.com<mailto:jeff.neuman@comlaude.com> From: Gnso-newgtld-wg <gnso-newgtld-wg-bounces@icann.org<mailto:gnso-newgtld-wg-bounces@icann.org>> On Behalf Of Rubens Kuhl Sent: Tuesday, September 24, 2019 10:22 PM To: gnso-newgtld-wg@icann.org<mailto:gnso-newgtld-wg@icann.org> Subject: Re: [Gnso-newgtld-wg] GNSO Council Response to ICANN Board on Potential dependencies between the Name Collisions Analysis Project (NCAP) and New gTLD Subsequent Procedures. The notion that Work Track 4 already covered all the know evidence of harm is not accurate. If the Board were willing to rest on what Work Track 4 had, it would never have initiated the NCAP as an OCTO project. Board never considered WT4 output, since it will only be sent to the Board in the final report. And due to lack of consensus, most discussions in WT4 will never reach Board at all, so saying that it was considered is too far fetched. Rubens ________________________________ The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that the Com Laude Group does not accept any responsibility for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities. The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England and Wales with company number 06181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176, having its registered office at 33 Melville Street, Edinburgh, Lothian, EH3 7JF Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, headquartered at 1751 Pinnacle Drive, Suite 600, McLean, VA 22102, USA; Com Laude (Japan) Corporation, a company registered in Japan having its registered office at Suite 319,1-3-21 Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan. For further information see www.comlaude.com<https://comlaude.com> ________________________________ This message and any attachments are intended only for the use of the individual or entity to which they are addressed. If the reader of this message or an attachment is not the intended recipient or the employee or agent responsible for delivering the message or attachment to the intended recipient you are hereby notified that any dissemination, distribution or copying of this message or any attachment is strictly prohibited. If you have received this communication in error, please notify us immediately by replying to the sender. The information transmitted in this message and any attachments may be privileged, is intended only for the personal and confidential use of the intended recipients, and is covered by the Electronic Communications Privacy Act, 18 U.S.C. §2510-2521. ________________________________ The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that the Com Laude Group does not accept any responsibility for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities. The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England and Wales with company number 06181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176, having its registered office at 33 Melville Street, Edinburgh, Lothian, EH3 7JF Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, headquartered at 1751 Pinnacle Drive, Suite 600, McLean, VA 22102, USA; Com Laude (Japan) Corporation, a company registered in Japan having its registered office at Suite 319,1-3-21 Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan. For further information see www.comlaude.com<https://comlaude.com>